Domain experts in niche, complex, or seemingly "boring" fields have a significant competitive advantage in tech. The small overlap between deep industry knowledge and software skills creates a natural moat, allowing them to solve problems broader tech companies overlook.

Nobel laureates are 22x more likely to have diverse hobbies, but this breadth is an advanced skill. The optimal path is to first specialize in a field to differentiate yourself. Only after achieving a level of mastery should you broaden your learning to connect disparate ideas and drive innovation.

While diversification is preached for managing risk, the world's most successful investors build wealth through concentration. They make a few large bets in areas where they have a distinct advantage or "alpha," rather than spreading their capital thinly across the market.

Due to the nascent and highly specialized nature of AI, VCs find that traditional expert networks are no longer effective for diligence. Instead, they must rely on curated personal networks of deep specialists who can genuinely assess new technologies and teams.

In biotech investing, the collective wisdom of specialists is more valuable than any single expert's contrarian bet. Stocks owned by multiple specialists perform better, suggesting that an individual specialist's unique, high-alpha idea is more likely to be wrong than right.

The most reliable returns often come from "eclectic royalties"—companies dominating a niche market, effectively collecting a toll on a small part of the economy. A leader in commercial ice machines, for example, can be a more competitive investment than trying to predict the ultimate winner in a crowded field like AI.

Resist the common trend of chasing popular deals. Instead, invest years in deeply understanding a specific, narrow sector. This specialized expertise allows you to make smarter investment decisions, add unique value to companies, and potentially secure better deal pricing when opportunities eventually arise.

In a generalist model, learnings from one industry rarely transfer to the next. Sector specialists benefit from compounding knowledge, where every lesson from one deal is directly applied to the next. This accelerates expertise and creates a powerful, self-reinforcing playbook for value creation.

In venture capital, mid-sized generalist funds struggle to compete. They lack the scale and network of large generalists and the deep expertise of small specialists. This 'death of the middle' makes it difficult for them to win the best, most competitive deals against firms that can offer either breadth or depth.